Cross-sectional survey of antimicrobial prescribing patterns in UK small animal veterinary practice

Preventive Veterinary Medicine

Volumn 104, Issue 3-4, 2012, Pages 309-316

  Hughes, Laura A ^a   Williams, Nicola ^a   Clegg, Peter ^a   Callaby, Rebecca ^a   Nuttall, Tim ^a   Coyne, Karen ^a   Pinchbeck, Gina ^a   Dawson, Susan ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Antibiotic resistance; Antimicrobial prescribing patterns; Small animal practice

Indexed keywords

ANTIINFECTIVE AGENT;

ANIMAL; ARTICLE; CAT; CAT DISEASE; CROSS-SECTIONAL STUDY; DOG; DOG DISEASE; DRUG UTILIZATION; HUMAN; PROFESSIONAL PRACTICE; QUESTIONNAIRE; STATISTICAL MODEL; STATISTICS; UNITED KINGDOM; VETERINARY MEDICINE;

ANIMALS; ANTI-BACTERIAL AGENTS; CAT DISEASES; CATS; CROSS-SECTIONAL STUDIES; DOG DISEASES; DOGS; DRUG UTILIZATION; GREAT BRITAIN; HUMANS; LOGISTIC MODELS; PROFESSIONAL PRACTICE; QUESTIONNAIRES; VETERINARIANS; VETERINARY MEDICINE;

ANIMALIA; CANIS FAMILIARIS;

EID: 84858798795     PISSN: 01675877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.prevetmed.2011.12.003     Document Type: Article

References (39)

1. Balabanova Y., Fedorin I., Kuznetsov S., Graham C., Ruddy M., Atun R., Coker R., Drobniewski F. Antimicrobial prescribing practices for respiratory diseases including tuberculosis in Russia: a possible role in drug resistance?. Journal of Antimicrobial Chemotherapy 2004, 54:673-679.
2. Bantar C., Sartori B., Vesco E., Heft C., Saul M., Salamone F., Oliva M.E. A hospitalwide intervention program to optimise the quality of antibiotic use: impact on prescribing practice, antibiotic consumption, cost savings and bacterial resistance. Clinical Infectious Diseases 2003, 37:180-186.
3. Barton M.D. Is it responsible to use third generation cephalosporins to treat animals?. Australian Veterinary Journal 2001, 79:620.
4. Boerlin P., White D.G. Antimicrobial resistance and its epidemiology. Antimicrobial Therapy in Veterinary Medicine 2006, 27-43. Blackwell Publishing, Iowa, USA. 4th edition. S. Giguere, J.F. Prescott, J.D. Baggot, R.D. Walker, P.M. Dowling (Eds.).
5. BSAVA BSAVA Small Animal Formulary 2008, British Small Animal Veterinary Association, Gloucester. 6th edition.
6. BSAVA, 2010. BSAVA guide to the use of veterinary medicines.
7. Choe C.H., Bouhaouala S.S., Brook I., Elliot T.B., Knudson G.B. In vitro development of resistance to ofloxacin and doxycycline in Bacillus anthracis Sterne. Antimicrobial Agents and Chemotherapy 2000, 44:1766.
8. Dellit T.H., Owens R.C., McGowan J.E., Gerding D.N., Weinstein R.A., Burke J.P., Huskins W.C., Paterson D.L., Fishman N.O., Carpenter C.F., Brennan P.J., Billeter M., Hooton T.M. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clinical Infectious Diseases 2007, 44:159-177.
9. Donaldson, L. 2009. 150 years of the annual report of the chief medical officer: on the state of public health 2008.
10. EMEA, 1999. EMEA/CVMP/342/99 final report: antibiotic resistance in the European union associated with therapeutic use of veterinary medicines - report and qualitative risk assessment.
11. FVE, Antibiotic resistance & prudent use of antibiotics in veterinary medicine. Federation of Veterinarians of Europe, 2011. http://www.fve.org/news/publications/pdf/antibioen.pdf.
12. Gillespie S.H., Basu S., Dickens A.L., O'Sullivan D.M., McHugh T.D. Effect of subinhibitory concentrations of ciprofloxacin on Mycobacterium fortuitum mutation rates. Journal of Antimicrobial Chemotherapy 2005, 56:344-348.
13. Hawkey P.M., Jones A.M. The changing epidemiology of resistance. Journal of Antimicrobial Chemotherapy 2009, 64. i.3-i.10.
14. Lavilla S., Gonzalez-Lopez J.J., Sabate M., Garcia-Fernandez A., Larrosa M.N., Bartolome R.M., Carattoli A., Prats G. Prevalence of qnr genes among extended-spectrum beta-lactamase-producing enterobacterial isolates in Barcelona, Spain. Journal of Antimicrobial Chemotherapy 2008, 61:291-295.
15. Levy S.B. Multidrug resistance - a sign of the times. New England Journal of Medicine 1998, 338:1376-1378.
16. Martin C., Ofotokun I., Rapp R., Empey K., Armitstead J., Pomeroy C., Hoven A., Evans M. Results of an antimicrobial control program at a university hospital. American Journal of Health-System Pharmacy 2005, 62:732-738.
17. McGavin M.D., Zachary J.F. Pathologic Basis of Veterinary Disease 2007, Mosby, Elsevier, Missouri, USA. 4th edition.
18. Moodley A., Stegger M., Bagcigil A.F., Baptiste K.E., Loeffler A., Lloyd D.H., Williams N.J., Leonard N., Abbott Y., Skov R., Guardabassi L. spa typing of methicillin-resistant Staphylococcus aureus isolated from domestic animals and veterinary staff in the UK and Ireland. Journal of Antimicrobial Chemotherapy 2006, 58:1118-1123.
19. NOAH. 2010. National Office of Animal Health Compendium of Data Sheets for Animal Medicines.
20. Odensvik K., Grave K., Greko C. Antibacterial drugs prescribed for dogs and cats in Sweden and Norway 1990-1998. Acta Veterinaria Scandinavica 2001, 42:189-198.
21. Prescott J.F., Hanna W.J.B., Reid-Smith R., Drost K. Antimicrobial drug use and resistance in dogs. Canadian Veterinary Journal 2002, 43:107-116.
22. Rankin S., Roberts S., O'Shea K., Maloney D., Lorenzo M., Benson C.E. Panton valentine leukocidin (PVL) toxin positive MRSA strains isolated from companion animals. Veterinary Microbiology 2005, 108:145-148.
23. Rantala M., Holso K., Lillas A., Huovinen P., Kaartinen L. Survey of condition-based prescribing of antimicrobial drugs for dogs at a veterinary teaching hospital. The Veterinary Record 2004, 155:259-262.
24. Regal R.E., DePestel D.D., VandenBussche H.L. The effect of an antimicrobial restriction program on Pseudomonas aeruginosa resistance to beta-lactams in a large teaching hospital. Pharmacotherapy 2003, 23:618-624.
25. Rutland B.E., Weese J.S., Bolin C., Au J., Malani A.N. Human-to-dog transmission of methicillin-resistant Staphylococcus aureus. Emerging Infectious Diseases 2009, 15:1328-1330.
26. Schwarz S., Chaslus-Dancla E. Use of antimicrobials in veterinary medicine and mechanisms of resistance. Veterinary Research 2001, 32:201-225.
27. Smith R. Medical journals and pharmaceutical companies: uneasy bedfellows. British Medical Journal 2003, 326:1202-1208.
28. Stamey T.A., Bragonje J. Resistance to naladixic acid. A misconception due to underdosing. Journal of the American Medical Association 1976, 236:1857-1860.
29. Van Duijkeren E., Wolfhagen M.J., Heck M.E., Wannet W.J. Transmission of a panton-valentine leucocidin-positive, methicillin-resistant Staphylococcus aureus strain between humans and a dog. Journal of Clinical Microbiology 2005, 43:6209-6211.
30. Vanni M., Tognetti R., Pretti C., Crema F., Soldani G., Meucci V., Intorre L. Antimicrobial susceptibility of Staphylococcis intermedius and Staphylococcus schleiferi isolated from dogs. Research in Veterinary Science 2009, 87:192-195.
31. VMD. 2009. Sales of antimicrobial products authorised for use as veterinary medicines, antiprotozoals, antifungals and coccidiostats, in the UK in 2008.
32. VMD. 2010. Veterinary Medicines Directorate Product Information Database.
33. Walker R.D., Giguere S. Principles of antimicrobial drug selection and use. Antimicrobial Therapy in Veterinary Medicine 2006, 107-117. Blackwell Publishing, Iowa, USA. 4th edition. S. Giguere, J.F. Prescott, J.D. Baggot, R.D. Walker, P.M. Dowling (Eds.).
34. Watson A.D.J. A survey of antibacterial drug use in cats. Australian Veterinary Practitioner 1990, 20:188-193.
35. Watson A.D.J., Maddison J.E. Systemic antibacterial drug use in dogs in Australia. Australian Veterinary Journal 2001, 79:740-746.
36. Weese J.S. Investigation of antimicrobial use and the impact of antimicrobial use guidelines in a small animal veterinary teaching hospital: 1995-2004. Journal of the American Veterinary Medical Association 2006, 228:553-558.
37. Westgarth C., Pinchbeck G.L., Bradshaw J.W., Dawson S., Gaskell R.M., Christley R.M. Factors associated with dog ownership and contact with dogs in a UK community. BMC Veterinary Research 2007, 3:5.
38. Westgarth C., Pinchbeck G.L., Bradshaw J.W., Dawson S., Gaskell R.M., Christley R.M. Dog-human and dog-dog interactions of 260 dog-owning households in a community in Cheshire. Veterinary Record 2008, 162:436-442.
39. White A.C.J., Atmar R.L., Wilson J., Cate T.R., Stager C.E., Greenberg S.B. Effects of requiring prior authorization for selected antimicrobials: expenditures, susceptibilities, and clinical outcomes. Clinical Infectious Diseases 1997, 25:230-239.